Results Eleven randomized clinical trials (14 publications), eight meta-analyses and/or systematic reviews, and one prospective cohort study met the inclusion criteria for this systematic review.

Treatment with prademagene zamikeracel was safe and well tolerated, with few, non-serious treatment-related adverse events, consistent with previous clinical trials. 19,20 There was no evidence of ...

Clinical guidelines broadly recommend exercise training for patients with heart failure (HF). This review examines clinical benefits of exercise training across HF subtypes, focusing on clinical ...

Revolution Medicines and Summit Therapeutics Enter into Clinical Collaboration to Evaluate Combinations of Three RAS (ON) Inhibitors with Ivonescimab in RAS Mutant Tumors ...

In his closing argument, Marc Agnifilo joked to jurors and contended that the music mogul’s girlfriends had willingly participated in sex marathons.

In a first step toward FDA approval of kidney xenotransplantation, a living human with end-stage kidney disease may receive a pig organ as soon as this summer as part of a clinical trial program ...

From bodybuilding to beating cancer: Trials, treatment put woman on road to remission Despite her commitment to fitness, Bianca Harvey received a life-altering cancer diagnosis at age 34.

Oncology practitioners and health systems in sub-Saharan Africa need to be aware of the possible presence of substandard anticancer products when designing care protocols and evaluating patient ...

Prosecutors streamline the case against Sean "Diddy" Combs by removing attempted kidnapping, arson and aiding sex trafficking charges before trial's conclusion.

At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of an AA battery.

Open in Viewer Table 1. Clinical Trial Shortcomings for VTE/ATE Reporting, Their Associated Adverse Consequences, and Proposed Specific Solutions for Inconsistent and Inaccurate Venous and Arterial ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.